Oncopeptides (STO: ONCO)

Last close As at 08/07/2025

SEK2.22

0.48 (27.59%)

Market capitalisation

SEK368m

Oncopeptides is focussed on the development and commercialisation of targeted therapies for difficult-to-treat cancers.

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Sofia Heigis

    CEO

  • Henrik Bergentoft

    CFO

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free